2O PD-1 defines a distinct, functional, tissue-adapted state in V-delta-1+ T cells with implications for cancer immunotherapy

Cancer Immunotherapy Atezolizumab
DOI: 10.1016/j.annonc.2023.09.1505 Publication Date: 2023-10-20T12:10:22Z